Document is current
Any future updates will be listed below
-
Authors
Li, Deyi
Chan, Ho Yin
Yu, Alan S. L. https://orcid.org/0000-0002-1776-2533
Kellum, John A. https://orcid.org/0000-0003-1995-2653
Fuhrman, Dana Y.
Chrischilles, Elizabeth A.
Cowell, Lindsay G.
Chandaka, Sravani
Kean, Jacob
McTigue, Kathleen M.
Mosa, Abu Saleh Mohammad https://orcid.org/0000-0002-8956-1466
Taylor, Bradley https://orcid.org/0000-0002-6414-4172
Waitman, Lemuel R.
Syed, Mahanaz
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01DK116986)
National Science Foundation (2444044)
- License Information
-
More Information
Article History
Received: 24 October 2024
Accepted: 25 June 2025
First Online: 3 July 2025
Competing interests
: J.A.K. discloses paid consulting from BioMérieux, AstraZeneca, Bayer, Chugai Pharma, Mitsubishi Tanabe, and Novartis, and is a full-time employee of Spectral Medical, all unrelated to the present work. K.M.M. has led and participated in research studies funded by Pfizer, Amgen, and Eli Lilly, all unrelated to the present work. A.S.L.Y. has served as consultant or on advisory boards for Regulus, Calico, Janssen and Sarepta, none of which are related to the current work. The remaining authors declare no competing interests.
